Melanie Sena is community editor of Pharmaceutical Technology.
Novartis receives FDA breakthrough therapy designation for Bexsero, a meningitis B vaccine.
Immunovaccine's vaccine technology chosen for cervical, head, and neck cancer trials conducted by Dana-Farber Institute.
EMA notifies EU healthcare professionals of the falsified cancer drug Herceptin.
A new report from PhRMA outlines potential growth trajectories affecting the biopharmaceutical industry.
CBER will move to the FDA White Oak campus in Silver Spring, Maryland.
The Advanced Tissue-engineered Human Ectypal Network Analyzer project team is developing realistic human organs for testing.
uniQure appoints a new COO and vice president, Medical affairs.
FDA develops an assay that could speed the release of pandemic influenza vaccines.
Eli Lilly will present early-stage data regarding cancer therapies at AACR 2014.